BMY Bristol Myers Squibb Co

Bristol-Myers Squibb (NYSE:BMY) posted a modest gain after a double beat on earnings. The company continues to display strong fundamentals and a robust pipeline. Although growth investors may not be pleased, Bristol-Myers Squibb stock remains a strong value stock. Bristol-Myers Squibb Co (NYSE:BMY) posted a small gain after an earnings report; the company beat its […]
https://www.valuewalk.com/strong-fundamentals-make-bristol-myers-squibb-stock-a-real-value/